The 16-Layer HBM3e chips are expected to roll-out in 2025 New chips offer improved AI learning and inference capabilities ...

Viking's candidates, like Eli Lilly's, fall into the dual GLP-1/GIP category. The results of these commercialized treatments, ...

"The new panel's maximum elongation rate has more than doubled from 20% to 50%," said the press release. "This enhanced ...

A Swiss-engineered robot can climb ladders, showing why it's at the cutting edge of autonomous robotic solutions for harsh ...

From November onwards, the Suntory Group will successively introduce these bio-PET bottles for selected products in Japan.

Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

The recent U.S. election might appear bad for climate tech, but the energy transition has enough financial momentum that ...

It's worth highlighting that Sarepta Therapeutics, Inc.'s (SRPT) Eteplirsen would be DYNE-251's main competitor if ...

“It allows you to take a step back. You get the authentic Caribbean vibe without it being too commercialized. Even as someone ...

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...

Although Sotyktu's patents start expiring in 2026, it is estimated that generic versions may not hit the market until late 2033. HC Wainwright models peak sales of around $1.9 billion for ESK-001 ...

The L.A. arts community is already worried about slow planning for the cultural festival accompanying the 2028 L.A. Olympics.